Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use
Completed
- Conditions
- GERD
- Registration Number
- NCT00691171
- Lead Sponsor
- AstraZeneca
- Brief Summary
The purpose of the study is to examine the impact of augmented, high-quality physician-coordinated care executed via an electronic health record (EHR)-based intervention on quality of care for gastroesophageal reflux disease (GERD) and for gastroprotection for patients on chronic non-steroidal anti-inflammatory drugs (NSAIDs) at increased risk for upper GI tract ulcers and ulcer related complications.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5234
Inclusion Criteria
- Eligibility as determined by criteria for participation in studies as part of the MQIC
- Agreement of participating clinical practices to undergo training in the electronic health record (EHR) intervention designed for this study
Read More
Exclusion Criteria
- Based on voluntary participation by MQIC practices, so practices were excluded if they decided to opt out
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnoses of GERD After 12 months of intervention Prescriptions for gastroprotective medicines in at-risk, chronic NSAID users After 12 months of intervention
- Secondary Outcome Measures
Name Time Method NSAID-related GI complications After 12 months of intervention Prescriptions for GERD medications After 12 months of intervention Change in GERD symptoms score After 12 months of intervention